Pharmacological management of hypertension in adults: updates from Eighth Joint National Committee

Ashwin Kamath

Abstract


The choice of first-line antihypertensive drug(s) is a matter of intensive research despite the availability of data from large, randomized, and controlled clinical trials. The Eighth Joint National Committee (JNC) guideline on management of high blood pressure (BP) in adults has significant updates over the earlier guidelines.

Keywords


Antihypertensive, Guidelines

Full Text:

PDF

References


James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-20. [DOI via Crossref]

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. [DOI via Crossref]

Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. [DOI via Crossref]